Reference priceKRW ₩850,500.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Bomyntra |
|---|---|
| Manufacturer | Fresenius Kabi Deutschland GmbH |
| Prescription required | Yes |
Bomyntra 120mg Injektionsl sung,1St x 1.7ml(denosumab)
denosumab
Description
Bomyntra 120mg Injektionsl sung,1St x 1.7ml(denosumab) is a medicine catalog record in the MediPriceHub database. Active ingredient: denosumab. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Fresenius Kabi Deutschland GmbH. Therapeutic category: Medicine Library > Oncology Medicines > Giant cell tumor of bone. Pack information: 120, 1 x 1.7. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Bomyntra is a RANK ligand (RANKL) inhibitor indicated for: Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity. Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.How to Use
Use denosumab under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: denosumab. Pack size: 120, 1 x 1.7. Pack unit: bottle. Manufacturer: Fresenius Kabi Deutschland GmbH. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Giant cell tumor of bone. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.